The Wasatch U.S. Select Fund—Investor Class gained 0.24% but underperformed the benchmark Russell 3000® Growth Index, which ...

Laidlaw analyst Yale Jen initiated coverage of Nuvectis Pharma (NVCT) with a Buy rating and $19 price target Nuvectis is an early to ...

Avance Clinical CEOYvonne Lungershausen emphasized the importance of these new partnerships and highlighted the value of ...

AstraZeneca will buy all outstanding equity of EsoBiotec for on a cash and debt-free basis, which includes an initial payment ...

Last year, Novartis agreed to buy U.S.-based Mariana Oncology for $1 billion upfront to expand its portfolio of the drugs, ...

Sri Lanka has expressed its willingness to invest in joint ventures in Bangladesh, particularly in synthetic fabric manufacturing, which holds significant potential for investors from both nations, Sr ...